Related Experiment Videos
Antibiotic-associated pseudomembranous colitis in siblings
Pediatrics
|December 1, 1980
Insights
Antibiotic-induced pseudomembranous colitis is rare in children. This study highlights cholestyramine as a potential treatment, alerting pediatricians to this condition.
Area of Science:
- Pediatric Gastroenterology
- Infectious Diseases
- Microbiome Research
Background:
- Antibiotic-associated diarrhea is common in children.
- Pseudomembranous colitis (PMC) is an underdiagnosed cause of severe antibiotic-associated diarrhea.
- Recent research has elucidated the pathogenesis of PMC.
Observation:
- Two siblings presented with symptoms suggestive of pseudomembranous colitis.
- The cases occurred following antibiotic administration.
- Clinical presentation and diagnostic findings were consistent with PMC.
Findings:
- The study identified pseudomembranous colitis in pediatric patients.
- Cholestyramine was considered a potentially effective therapeutic agent.
- The cases underscore the importance of considering PMC in the differential diagnosis.
Implications:
- Pediatricians should consider pseudomembranous colitis in children with severe diarrhea after antibiotic use.
- Early diagnosis and appropriate management, potentially including cholestyramine, can improve outcomes.
- Further research into pediatric PMC pathogenesis and treatment is warranted.
Abstract:
Pseudomembranous colitis induced by antibiotics is not commonly diagnosed in children. Recent developments have clarified the pathogenesis and suggested that agents such as cholestyramine are therapeutically useful. Two siblings with pseudomembranous colitis were carefully studied and may serve to alert pediatricians to an approach to this entity.